What Makes IRADIMED CORPORATION (IRMD) a Compelling Opportunity?

3 months ago 43

Soumya Eswaran

Tue, December 16, 2025 astatine 9:48 AM CST 2 min read

Riverwater Partners, an concern absorption company, released its “Micro Opportunities Strategy” Q3 2025 capitalist letter. The strategy reported affirmative returns successful the 4th but lagged its benchmark arsenic it did not support gait with the beardown rally. The strategy continues to absorption connected prime companies successful the volatile environment. In addition, you tin cheque the fund’s apical 5 holdings to find its champion picks for 2025.

In its third-quarter 2025 capitalist letter, Riverwater Partners Micro Opportunities Strategy highlighted stocks specified arsenic IRADIMED CORPORATION (NASDAQ:IRMD). Headquartered successful Winter Springs, Florida, IRADIMED CORPORATION (NASDAQ:IRMD) is simply a magnetic resonance imaging (MRI) compatible aesculapian instrumentality manufacturer. The one-month instrumentality for IRADIMED CORPORATION (NASDAQ:IRMD) was 13.54%, and its shares gained 84.62% implicit the past 52 weeks. On December 15, 2025, IRADIMED CORPORATION (NASDAQ:IRMD) banal closed astatine $97.02 per share, with a marketplace capitalization of $1.244 billion.

Riverwater Partners Micro Opportunities Strategy stated the pursuing regarding IRADIMED CORPORATION (NASDAQ:IRMD) successful its 3rd 4th 2025 capitalist letter:

"Our Healthcare holdings delivered coagulated contributions, led by IRADIMED CORPORATION (NASDAQ:IRMD). IRMD's MRI-compatible devices person gained marketplace share, and the company's beardown recurring gross exemplary and fantabulous returns connected invested superior marque it an perfect acceptable for our quality-focused approach. We proceed to presumption aesculapian exertion arsenic a compelling subsector offering combining semipermanent maturation opportunities with tenable valuations."

IRADIMED CORPORATION (NASDAQ:IRMD) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. As per our database, 14 hedge money portfolios held IRADIMED CORPORATION (NASDAQ:IRMD) astatine the extremity of the 3rd quarter, which was 13 successful the erstwhile quarter. In Q3 2025, IRADIMED CORPORATION (NASDAQ:IRMD) reported grounds gross of $21.2 million, marking an summation of 16% from Q3 2024. While we admit the imaginable of IRADIMED CORPORATION (NASDAQ:IRMD) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

In another article, we covered IRADIMED CORPORATION (NASDAQ:IRMD) and shared the database of champion small-cap stocks with immense imaginable according to Reddit arsenic marketplace looks beyond AI trade. In addition, delight cheque retired our hedge money capitalist letters Q3 2025 page for much capitalist letters from hedge funds and different starring investors.